Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Perrigo Company    PRGO

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 5 681 M
EBIT 2016 1 663 M
Net income 2016 577 M
Debt 2016 4 595 M
Yield 2016 0,45%
Sales 2017 6 000 M
EBIT 2017 1 785 M
Net income 2017 839 M
Debt 2017 3 837 M
Yield 2017 0,80%
P/E ratio 2016 33,21
P/E ratio 2017 19,00
EV / Sales 2016 3,24x
EV / Sales 2017 2,95x
Capitalization 13 837 M
More Financials
Company
Perrigo Co. Plc engages in the production of over-the-counter consumer goods and specialty pharmaceutical products.It operates through the following segments: Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals, and Specialty Sciences.The CHC segment includes... 
Sector
Pharmaceuticals
Calendar
10/20Earnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY
05/27DJJOSEPH PAPA : Correction to Valeant CEO Article on April 21
05/25 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Perrigo Comp..
05/25 ROBBINS ARROYO LLP : Perrigo Company plc (PRGO) Misled Shareholders According to..
05/25 PERRIGO COMPANY PLC : ex-dividend day
05/24 PERRIGO COMPANY PLC : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of C..
05/24 Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against..
05/19 BERNSTEIN LIEBHARD LLP : Announces That A Suit Has Been Filed Against Perrigo Co..
05/18 BERNSTEIN LITOWITZ BERGER & GROSSMAN : Announces Securities Class Action Suit Fi..
05/17 BRIEF : Perrigo restates Q1 loss
05/17DJPerrigo Updates First-Quarter Loss Figure to Reflect Lower Tax Benefit
More news
Sector news : Pharmaceuticals - NEC
05/29 JOHNSON & JOHNSON : Telling the stories of a son fallen in combat, and also vete..
05/28 SUN PHARMACEUTICAL : Pharma Q4 profit seen up 113%, Gleevec may drive US sales
05/28 TAKEDA PHARMACEUTICAL : Receives Positive CHMP Opinion for ADCETRIS (brentuximab..
05/28DJCovestro Eyes Acquisitions, Says Finance Chief - Report
05/28DJSUBSCRIBERS : Covestro News Reported in April
More sector news : Pharmaceuticals - NEC
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions